Regional Therapy for Recurrent Metastatic Melanoma Confined to the Extremity: Hyperthermic Isolated Limb Perfusion vs. Isolated Limb Infusion. - Wikidata - awgldk - TriplyDB

Regional Therapy for Recurrent Metastatic Melanoma Confined to the Extremity: Hyperthermic Isolated Limb Perfusion vs. Isolated Limb Infusion.

Regional Therapy for Recurrent Metastatic Melanoma Confined to the Extremity: Hyperthermic Isolated Limb Perfusion vs. Isolated Limb Infusion.

http://www.wikidata.org/entity/Q37307175

about

Current trends in regional therapy for melanoma: lessons learned from 225 regional chemotherapy treatments between 1995 and 2010 at a single institution.Isolated limb infusion chemotherapy for melanoma: an overview of early experience at the Adelaide Melanoma Unit.

P2860

Q35127039-22307031-0072-452B-8AB6-0E2075F08137 Q37120289-27F5FC0A-D0E4-4855-9DC5-408BBF5FEA95

P2860

Regional Therapy for Recurrent Metastatic Melanoma Confined to the Extremity: Hyperthermic Isolated Limb Perfusion vs. Isolated Limb Infusion.

http://www.wikidata.org/entity/Q37307175

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 10 February 2010

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Regional Therapy for Recurrent ...... on vs. Isolated Limb Infusion.

@en

Regional Therapy for Recurrent ...... on vs. Isolated Limb Infusion.

@nl

type

label

Regional Therapy for Recurrent ...... on vs. Isolated Limb Infusion.

@en

Regional Therapy for Recurrent ...... on vs. Isolated Limb Infusion.

@nl

prefLabel

Regional Therapy for Recurrent ...... on vs. Isolated Limb Infusion.

@en

Regional Therapy for Recurrent ...... on vs. Isolated Limb Infusion.

@nl

P1433

Q37307175-2F742A62-3067-4B40-9279-C30657F905CA

P1476

Q37307175-E6BEA24C-CB85-4CC0-BAAD-1D1986CE8638

P2093

Q37307175-2440A2B0-CFE6-4F1F-AE4A-902F094BB2D1

Q37307175-46421914-E2E6-4D73-B957-23D54E9F4BCB

Q37307175-48E2FB4B-3261-4065-A3C4-49A99FD7A2F0

Q37307175-5D0595D2-307F-47CC-AE16-22BF1A2054D9

Q37307175-82E804D6-7E9D-458B-83BB-1A8BC49DEFD6

Q37307175-F6EF6010-5ECD-4DE1-9ECA-7A8F4FEEFCD0

P2860

Q37307175-07F7D656-56CA-42B0-9182-1815E994102F

Q37307175-1258BF6E-2822-4E19-BA55-CC5807FC159F

Q37307175-1C9F93FA-50CF-4416-A28A-FDD8D62A9E11

Q37307175-1EDCBDD1-D677-47E9-B7A2-D3C026222D14

Q37307175-2F607E2A-C515-4FE1-A7C0-6B2F6B49E3DA

Q37307175-A9A70B72-FDA2-46D5-A961-4592263DA6B5

Q37307175-F0A2239D-B0C2-4DD7-9948-138E4BAD842D

P304

Q37307175-63354E41-A7A9-478C-84F2-B8BC3734B2BC

P31

Q37307175-EE419979-0AA4-43EC-816C-23BB96ED8FC7

P356

Q37307175-A3FE4B25-F76C-4081-8224-A723C1A4F02D

P433

Q37307175-001598D6-4924-427A-91FD-D2D8711627FB

P478

Q37307175-1CCFEC8F-6F5C-4ECB-A067-481ECB8C1C81

P577

Q37307175-A739CABE-B0B9-467C-A94E-380E48F48F34

P5875

Q37307175-A9A65E3D-2D96-4F0A-8324-263171DB2F1B

P698

Q37307175-D593EDD9-383D-4CBC-AC03-F9941C94B9F1

P932

Q37307175-2386F468-8BA2-43CC-A31A-EA26EB1D2824

P356

CANCERS20100043

P1433

P1476

Regional Therapy for Recurrent ...... on vs. Isolated Limb Infusion.

@en

P2093

Christian Reintgen

http://www.w3.org/2001/XMLSchema#string

Christopher Nobo

http://www.w3.org/2001/XMLSchema#string

Douglas Reintgen

http://www.w3.org/2001/XMLSchema#string

Michael Reintgen

http://www.w3.org/2001/XMLSchema#string

Rosemary Giuliano

http://www.w3.org/2001/XMLSchema#string

Steven Shivers

http://www.w3.org/2001/XMLSchema#string

P2860

Efficacy of repeat isolated limb perfusions with tumor necrosis factor alpha and melphalan for multiple in-transit metastases in patients with prior isolated limb perfusion failure.

A multi-institutional experience of isolated limb infusion: defining response and toxicity in the US.

Mortality, major amputation rates, and leukopenia after isolated limb perfusion with phenylalanine mustard for the treatment of melanoma.

Long-term morbidity after regional isolated perfusion with melphalan for melanoma of the limbs. The influence of acute regional toxic reactions.

Isolated limb infusion for in-transit malignant melanoma of the extremity: a well-tolerated but less effective alternative to hyperthermic isolated limb perfusion.

Outcomes following isolated limb infusion for melanoma. A 14-year experience.

A phase II trial of isolated limb infusion with melphalan and dactinomycin for regional melanoma and soft tissue sarcoma of the extremity.

P304

43-50

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3390/CANCERS20100043

http://www.w3.org/2001/XMLSchema#string

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

2

http://www.w3.org/2001/XMLSchema#string

P577

2010-02-10T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

258954690

http://www.w3.org/2001/XMLSchema#string

P698

24281032

http://www.w3.org/2001/XMLSchema#string

P932

3827590

http://www.w3.org/2001/XMLSchema#string